![Anu Muona](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anu Muona
Vorstandsvorsitzender bei Aranda Pharma Oy
Ursprung des Netzwerks ersten Grades von Anu Muona
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Aranda Pharma Oy
![]() Aranda Pharma Oy BiotechnologyHealth Technology Aranda Pharma Ltd. engages in the research and development of novel small molecules to combat prostate cancer and neurodegenerative diseases. The company was founded by Anu Muona, Milla Koistinaho, Jari Koistinaho, and Gundars Goldsteins in September 2015 and is headquartered in Kuopio, Finland.
6
| Holding Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anu Muona
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Stanford University | College/University | Corporate Officer/Principal | |
Pharmatory Oy
![]() Pharmatory Oy Medical DistributorsDistribution Services Pharmatory Oy provides pharmaceutical ingredients and related services. It specializes in route scouting, process research and development, scale-up and cGMP manufacturing of key intermediates and active pharmaceutical ingredients (APIs) with focus on quality operation and timely delivery. The company was founded in 2001 and is headquartered in Oulu, Finland. | Medical Distributors | President | |
University of Tampere | College/University | Doctorate Degree | |
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Kuopio | College/University | Doctorate Degree | |
Inveni Capital Oy
![]() Inveni Capital Oy Investment ManagersFinance Inveni Capital Oy is a venture capital investment firm with offices in Helsinki and Munich. The Finnish-German firm was founded in 2007. Their investors include the Finnish Industry Investment Ltd. as largest single investor, along with other private investors and funds as well as the University of Helsinki. | Investment Managers | Founder | |
Dassiet Oy
![]() Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Chairman | |
Osuuskunta KPY
![]() Osuuskunta KPY Financial ConglomeratesFinance Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland. | Financial Conglomerates | Director/Board Member | |
Suomen Bioteollisuus ry | Director/Board Member | ||
Medtentia International Ltd. Oy
![]() Medtentia International Ltd. Oy Medical SpecialtiesHealth Technology Medtentia International Ltd. Oy is a holding company that develops solutions for mitral valve repair based on its proprietary helix ring concept. It is a medical technology company that creates solutions for cardiac interventions. It provides proprietary, helix-shaped products to address the unmet need in cardiac surgery. The company was founded by Dan Mogren and Olli U. Keränen in 2002 by Olli Keränen and is headquartered in Espoo, Finland. | Medical Specialties | Director of Finance/CFO | |
Laurantis Pharma Oy
![]() Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman | |
Aplagon Oy
![]() Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Financial Conglomerates | Chief Executive Officer | |
Aalto University School of Business | College/University | Graduate Degree | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
University of Eastern Finland | College/University | Undergraduate Degree | |
Tarrex Biopharma Ltd.
![]() Tarrex Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Tarrex Biopharma Ltd develops pharmaceuticals. The company was founded by Kanyin E.Zhang and Xiaokun Zhang and is headquartered in Xiamen, China. | Pharmaceuticals: Major | Chief Executive Officer | |
Innovestor Oy
![]() Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Investor | |
Bone Index Finland Oy
![]() Bone Index Finland Oy Electronic Equipment/InstrumentsElectronic Technology Bone Index Finland Oy develops solutions for osteoporosis diagnostics. The firm specializes in the development of measuring devices for osteoporosis screening and diagnosis. The company was founded by Ossi Riekkinen and Janne Karjalainen in 2011 and is headquartered in Kuopio, Finland. | Electronic Equipment/Instruments | Chairman | |
Innovestor Ventures Oy
![]() Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Helsinki Innovation Services Ltd.
![]() Helsinki Innovation Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Helsinki, Helsinki Innovation Services Ltd. is a company that provides business and innovation-related consulting services. The company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Chief Operating Officer | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Rokote Laboratories Finland Oy
![]() Rokote Laboratories Finland Oy BiotechnologyHealth Technology Rokote Laboratories Finland Oy is a Finnish vaccine development company established in 2020 with premises located in Kuopio and Helsinki. The private company aims to consolidate the use of new vaccine technology and is currently developing a second-generation coronavirus vaccine. The company's focus is on developing a COVID-19 vaccine, with clinical trials set to begin this year. | Biotechnology | Director/Board Member | |
Dassiet Oy (Helsinki) | Director/Board Member | ||
Teitur Trophics ApS
![]() Teitur Trophics ApS BiotechnologyHealth Technology Teitur Trophics ApS develops novel treatments. The company is based in Aarhus, Denmark. The Danish company was founded by Simon Mølgaard, Mathias Kaas Ollendorff, Anders Dalby, Simon Glerup. Simon Mølgaard has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Neumirna Therapeutics ApS | Biotechnology | Director/Board Member |
Statistik
International
Finnland | 24 |
Schweden | 3 |
Dänemark | 3 |
Vereinigte Staaten | 2 |
China | 2 |
Sektoral
Health Technology | 12 |
Consumer Services | 6 |
Commercial Services | 6 |
Finance | 6 |
Distribution Services | 2 |
Operativ
Director/Board Member | 18 |
Founder | 6 |
Chairman | 4 |
Chief Executive Officer | 4 |
Private Equity Investor | 3 |